Chronic and regular use of statin prevents atrial fibrillation in period after cardiac surgery;Uso crônico e regular de estatina previne fibrilação atrial no pósoperatório de cirurgia cardíaca

Arquivos Brasileiros de Cardiologia

Volumn 95, Issue 5, 2010, Pages 614-620

  Alves, Renato Jorge ^a   Campos, Rodrigo Noronha ^a   Nakiri, Kenji ^a  

^a HOSPITAL BENEFICÊNCIA PORTUGUESA DE SÃO PAULO   (Brazil)

Author keywords

Arrhythmias, cardiac; Atrial fibrillation; Hydroxymethylglutaryl CoA reductases inhibitors therapeutic use; Postoperative care; Thoracic surgery

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; ELECTIVE SURGERY; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART MUSCLE REVASCULARIZATION; HEART SURGERY; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RISK FACTOR; TREATMENT DURATION;

EID: 78751556471     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2010005000129     Document Type: Article

References (29)

1. Leitch JW, Thomson D, Baird DK, Harris PJ. The importance of age as a predictor of atrial fibrillation and flutter after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1990;100(3):338-42.
2. Cox JL. A perspective of postoperative atrial fibrillation in cardiac operations. Ann Thorac Surg. 1993;56(3):405-9.
3. Brugada R, Tapscott T, Czernuszewicz GZ, Marian AJ, Iglesias A, Mont L, et al. Identification of a genetic locus for familial atrial fibrillation. N Engl J Med. 1997;336(13):905-11.
4. Patti G, Chello M, Candura D, Pasceri V, Covino E, Di Sciascio G. Randomized trial of atorvastatin for reduction of post-operative atrial fibrillation in patients undergoing cardiac surgery. results from the ARMYDA-3 (Atorvastatin for Reduction of Myocardial Dysrhythmias After cardiac surgery) study. Circulation. 2006;114(14):1455-61.
5. Ommen SR, Odell JA, Stanton MS. Atrial arrhythmias after cardiothoracic surgery. N Engl J Med. 1997;336(20):1429-34.
6. Bradley D, Creswell LL, Hogue CW Jr, Epstein AE, Prystowsky EN, Daoud EG/(American College of Chest Physicians). Pharmacologic prophylaxis: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest. 2005;128(2 Suppl.): 39-47.
7. Gaudino M, Andreotti F, Zamparelli R, Di Casteknuovo A, Nasso G, Burzotta F, et al. The-174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation: is atrial fibrillation an inflammatory complication? Circulation. 2003;108(Suppl. 1):195-9.
8. Young-Xu Y, Jabbour S, Goldberg R, Blatt CM, Graboys T, Bilchik B, et al. Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease. Am J Cardiol. 2003;92(12):1379-83.
9. Amar D, Zhang H, Heerdt PM, Park B, Fleisher M, Thaler H T. Statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein. Chest. 2005;128(5):3421-7.
10. Higgins TL, Estafanous FG, Loop FD, Beck GJ, Blum JM, Paranandi L. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients: a clinical severity score. JAMA. 1992;267(17):2344-8.
11. Sato S, Yamaguchi S, Schuessler RB, Boineau J P, Matsunaga Y, Cox JL. The effect of augmented atrial hypothermia on atrial refractory period, conduction, and atrial flutter/fibrillation in the canine heart. J Thorac Cardiovasc Surg. 1992;104(2):297-306.
12. Asher CR, Miller D P, Grimm RA, Cosgrove DM 3rd, Chung MK. Analysis of risk factors for development of atrial fibrillation early after cardiac valvular surgery. Am J Cardiol. 1998;82(7):892-5.
13. Roach GW, Kanchuger M, Mangano CM, Newman M, Nussmeier N, Walman R, et al. Adverse cerebral outcomes after coronary bypass surgery. N Engl J Med. 1996;335(25):1857-63.
14. Aranki S F, Shaw D P, Adams DH, Rizzo RJ, Couper GS, VanderVliet M, et al. Predictors of atrial fibrillation after coronary artery surgery: current trends and impact on hospital resources. Circulation. 1996;94(3):390-7.
15. Crystal E, Connolly SJ, Sleik K, Ginger TJ, Yusuf S. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis. Circulation. 2002;106(1):75-80.
16. Chung MK, Augostini RS, Asher CR, Pool D P, Grady TA, Zikri M, et al. Ineffectiveness and potentialproarrhythmia of atrial pacing for atrial fibrillation prevention after coronary artery bypass grafting. Ann Thorac Surg. 2000;69(4):1057-63.
17. Alves RJ, Geovannini GR, Brito G, Miguel GAS, Glauser VA, Nakiri K. Amiodarona em moderada dosagem previne fibrilação atrial aguda em pacientes com fatores de risco arritmogênicos no pós- operatório de cirurgia cardíaca. Arq Bras Cardiol. 2007;89(1):22-7.
18. Geovanini GR, Alves RJ, Brito G, Miguel AS, Glauser VA, Nakiri K. Fibrilação atrial no pós-operatório de cirurgia cardíaca: quem deve receber quimioprofilaxia? Arq Bras Cardiol. 2009;92(4):326-30.
19. Fontes ML, Mathew J P, Rinder HM, Zelterman D, Smith BR, Rinder CS. (Multicenter Study of Perioperative Ischemia (McSPI) Research Group). Atrial fibrillation after cardiac surgery/cardiopulmonary bypass is associated with monocyte activation. Anesth Analg. 2005;101(1):17-23.
20. Bruins P, te Velthuis H, Yazdanbakhsh A P, Jansen PG, van Hardevelt FW, de Beaumont, et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation. 1997;96(1):3542-8.
21. Downing SW, Edmunds L. Release of vasoactive substances during cardiopulmonary bypass. Ann Thorac Surg. 1992;54(6):1236-43.
22. Butler J, Pillai R, Rocker GM, Westaby S, Parker D, Shale DJ, et al. Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor. J Thorac Cardiovasc Surg. 1993;105(1):25-30.
23. Bonetti PO, Lerman LO, Napoli C, Lerman A. Statin effects beyond lipid lowering: are they clinically relevant? Eur Heart J. 2003;24(3):225-48.
24. Pound EM, Kang JX, Leaf A. Partitioning of polyunsaturated fatty acids, which prevent cardiac arrhythmias, into phospholipid cell membranes. J Lipid Res. 2001;42(3):346-51.
25. Ishida K, Kimura F, Imamaki M, Ishida A, Shimura H, Kohmo H, et al. Relation of inflammatory cytokines to atrial fibrillation after off-pump coronary artery bypass grafting. Eur J Cardiothorac Surg. 2006;29(4):501-5.
26. Gauthier TW, Scalia R, Murohara T, Guo J P, Lefer AM. Nitric oxide protects against leukocyte-endothelium interactions in the early stages of hypercholesterolemia. Arterioscler Thromb Vasc Biol. 1995;15 10):1652-9.
27. Chello M, Mastroroberto P, Patti G, D'Ambrosio A, Morichetti MC, Di Sciascio G, et al. Simvastatin attenuates leukocyte-endothelial interactions after coronary revascularization with cardiopulmonary bypass. Heart. 2003;89(5):538-43.
28. Chello M, Carassiti M, Agró F, Mastroroberto P, Pugliese G, Colonna D, et al. Simvastatin blunts the increase of circulating adhesion molecules after coronary artery bypass surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2004;18(5):605-9.
29. Howard PA, Barnes BJ. Potencial use of statins to prevent atrial fibrillation after coronary artery bypass surgery. Ann Pharmacother. 2008;42(2):253-8.